The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: A three-month, longitudinal clinical study

Rheumatology International

Volumn 29, Issue 1, 2008, Pages 37-42

  Cinar, Muhammet ^a   Dinc, Ayhan ^a   Simsek, Ismail ^a   Erdem, Hakan ^a   Koc, Bayram ^a   Pay, Salih ^a   Tunca, Yusuf ^a   Kilic, Selim ^a   Gul, Davud ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ankylosing spondylitis; Familial Mediterranean fever gene mutation; Non steroidal anti inflammatory drugs

Indexed keywords

ACEMETACIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DICLOFENAC; FLURBIPROFEN; INDOMETACIN; OMEPRAZOLE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANKYLOSING SPONDYLITIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL STUDY; DNA MICROARRAY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPEPSIA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TREATMENT RESPONSE;

EID: 53149105114     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0637-1     Document Type: Article

References (40)

1. A Anandarajah CT Ritchlin 2005 Treatment update on spondyloarthropathy Curr Opin Rheumatol 17 3 247 256 10.1097/01.bor.0000159926.42761.dd
2. DC Knockaert IG Malysse WE Peetermans 1989 Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy Clin Rheumatol 8 3 408 412 10.1007/BF02030357
3. P Langevitz A Livneh D Zemer J Shemer M Pras 1997 Seronegative spondyloarthropathy in familial Mediterranean fever Semin Arthritis Rheum 27 2 67 72 10.1016/S0049-0172(97)80007-8
4. P Atagunduz T Ergun H Direskeneli 2003 MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement Clin Exp Rheumatol 21 4 S35 S37
5. R Gershoni-Baruch Y Broza R Brik 2003 Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura J Pediatr 143 5 658 661 10.1067/S0022-3476(03)00502-X
6. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P et al (2000) MEFV mutations in Behçet's disease. Hum Mutat 16(3):271-272. doi:10.1002/1098-1004(200009)16:3<271::AID-HUMU16>3.0.CO;2-A
7. S Ozen Y Karaaslan O Ozdemir U Saatci A Bakkaloglu E Koroglu 1998 Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study J Rheumatol 25 12 2445 2449
8. S Ozen A Bakkaloglu E Yilmaz A Duzova B Balci R Topaloglu 2003 Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30 9 2014 2018
9. DR Booth JD Gillmore HJ Lachmann SE Booth A Bybee M Soytürk 2000 The genetic basis of autosomal dominant familial Mediterranean fever QJM 93 4 217 221 10.1093/qjmed/93.4.217
10. M Delpech G Grateau 2001 Genetically determined recurrent fevers Curr Opin Immunol 13 5 539 542 10.1016/S0952-7915(00)00255-7
11. E Rabinovich A Livneh P Langevitz N Brezniak E Shinar M Pras 2005 Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene Ann Rheum Dis 64 7 1009 1014 10.1136/ard.2004.029447
12. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 4 361 368 10.1002/art.1780270401
13. Gran JT, Husby G (2003) Epidemiology of ankylosing spondylitis. rheumatology. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weicman ME (eds) 3rd edn. vol 2. Spain, pp 1153-1159
14. S Garrett T Jenkinson LG Kennedy H Whitelock P Gaisford A Calin 1994 A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index J Rheumatol 21 12 2286 2291
15. A Livneh P Langevitz 2000 Diagnostic and treatment concerns in familial Mediterranean fever Best Pract Res Clin Rheumatol 14 3 477 498 10.1053/berh.2000.0089
16. van der Linden S, van der Heijde D (2003). Classification of spondyloarthropathies. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weicman ME (eds) Rheumatology, 3rd edn. vol 2. Spain, pp 1149-1151
17. M Dougados B Dijkmans M Khan W Maksymowych S van der Linden J Brandt 2002 Conventional treatments for ankylosing spondylitis Ann Rheum Dis 61 40 50
18. D van der Heijde N Bellamy A Calin M Dougados MA Khan S van der Linden 1997 Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group J Rheumatol 24 11 2225 2229
19. SD Jones A Steiner SL Garrett A Calin 1996 The bath ankylosing spondylitis patient global score (BAS-G) Br J Rheumatol 35 1 66 71 10.1093/rheumatology/35.1.66
20. A Calin S Garrett H Whitelock LG Kennedy J O'Hea P Mallorie 1994 A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index J Rheumatol 21 12 2281 2285
21. I Duman B Balaban I Tugcu K Dincer 2007 Familial mediterranean fever unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int 27 7 689 690 10.1007/s00296-006-0275-4
22. I Keles G Aydin A Tosun E Inal H Keles S Orkun 2006 Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature Rheumatol Int 26 9 846 851 10.1007/s00296-005-0080-5
23. I Uthman RA Hajj-Ali T Arayssi AF Masri F Nasr 2001 Arthritis in familial Mediterranean fever Rheumatol Int 20 4 145 148 10.1007/s002960100103
24. B Balaban E Yasar A Ozgul K Dincer TA Kalyon 2005 Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis Rheumatol Int 25 8 641 644 10.1007/s00296-004-0578-2
25. P KausIk NI El-Sobkie D Sheab AN Malaviya 1999 Familial mediterranean fever with HLAB27 positive ankylosing spondylitis in a young armenian man Clin Exp Rheumatol 17 387 388
26. M Younes MF Kahn O Meyer 2002 Hip involvement in patients with familial Mediterranean fever. A review of ten cases Joint Bone Spine 69 560 565 10.1016/S1297-319X(02)00452-9
27. NA Incel M Saracoglu HR Erdem 2003 Seronegative spondyloarthropathy of familial Mediterranean fever Rheumatol Int 23 41 43
28. M Tunca S Akar PN Hawkins SE Booth B Sengül TU Yavuzşen 2002 The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever Eur J Hum Genet 10 786 789 10.1038/sj.ejhg.5200900
29. E Yilmaz S Ozen B Balci A Duzova R Topaloglu N Besbas 2001 Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population Eur J Hum Genet 9 553 555 10.1038/sj.ejhg.5200674
30. HJ Lachmann B Sengül TU Yavuzşen DR Booth SE Booth A Bybee 2006 Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations Rheumatology (Oxford) 45 6 746 750 10.1093/rheumatology/kei279
31. S Yigit H Bagci O Ozkaya K Ozdamar K Cengiz T Akpolat 2008 MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience J Rheumatol 35 1 106 113
32. Ben-Chetrit E, Lerer I, Malamud E, Domingo C, Abeliovich D (2000) The E148Q mutation in the MEFV gene: is it a disease-causing mutation or sequence variant? Hum Mutat 5:385-386. doi:10.1002/(SICI)1098-1004(200004)15:4<385:: AID-HUMU22>3.0.CO;2-A
33. D Tchernitchko M Legendre C Cazeneuve A Delahaye F Niel S Amselem 2003 The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever Hum Mutat 22 339 340 10.1002/humu.9182
34. B Koc C Oktenli F Bulucu N Karadurmus SY Sanisoglu D Gul 2007 The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study J Rheumatol 34 10 2070 2075
35. A Karban E Dagan R Eliakim A Herman S Nesher B Weiss 2005 Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease Genes Immun 6 2 134 139 10.1038/sj.gene.6364156
36. JJ Chae G Wood SL Masters K Richard G Park BJ Smith 2006 The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production Proc Natl Acad Sci USA 103 9982 9987 10.1073/pnas.0602081103
37. JJ Chae HD Komarow J Cheng G Wood N Raben PP Liu 2003 Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis Mol Cell 11 591 604 10.1016/S1097-2765(03)00056-X
38. C Stehlik L Fiorentino A Dorfleutner JM Bruey EM Ariza J Sagara 2002 The PAAD/PYRINfamily protein ASC is a dual regulator of a conserved step in nuclear factor kappa-B activation pathways J Exp Med 196 1605 1615 10.1084/jem.20021552
39. G Singh N Kumari A Aggarwal N Krishnani R Misra 2007 Prevalence of subclinical amyloidosis in ankylosing spondylitis J Rheumatol 34 2 371 373
40. M Dougados 2001 Treatment of spondyloarthropathies. Recent advances and prospects in 2001 Joint Bone Spine 68 6 557 563 10.1016/S1297-319X(01)00328-1